Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-alpha 2b treatment.
Ascierto PA, Napolitano M, Celentano E, Simeone E, Gentilcore G, Daponte A, Capone M, Caracò C, Calemma R, Beneduce G, Cerrone M, De Rosa V, Palmieri G, Castello G, Kirkwood JM, Marincola FM, Mozzillo N.
Ascierto PA, et al.
J Transl Med. 2010 Aug 16;8:76. doi: 10.1186/1479-5876-8-76.
J Transl Med. 2010.
PMID: 20712892
Free PMC article.
Clinical Trial.